Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Articles

Interactions Between Insulin and Its Receptors After the Initial Binding Event: Functional Heterogeneity and Relationships to Insulin Degradation

  1. Jerrold M Olefsky,
  2. Masashi Kobayashi and
  3. Helen Chang
  1. Department of Medicine, University of Colorado School of Medicine Denver, Colorado, and the Denver Veterans Administration Hospital
Diabetes 1979 May; 28(5): 460-471. https://doi.org/10.2337/diab.28.5.460
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

We studied the rate at which insulin dissociates from adipocytes and the ability of these cells to degrade insulin as a function of the length of exposure to the hormone. As the length of the association phase increases, the overall rate of insulin dissociation decreases. After 6 min of association at 24°C, the t1/2 of dissociation is 8 min and after 90 min of association the t1/2 of dissociation is 32 min. This time-dependent slowing of dissociation is progressive until steady-state binding conditions are reached during the association phase; after this point (90 min at 24°C), no further slowing of dissociation occurs. Comparable results were seen at 37°C, and at either temperature essentially 100% of the bound insulin eventually dissociates from the cells. Thus, no tendency for irreversible binding was observed. Similar results were obtained with isolated plasma membranes, and a variety of inhibitors of cell functions failed to influence the time-dependent slowing of dissociation. This suggests that the processes responsible for the changes in dissociation rate are independent of intracellular factors and are inherent in the plasma membrane. The results are compatible with the concept that insulin initially binds to a low affinity (fast dissociating) receptor and that a minority of these complexes are then converted to a high affinity (slow dissociating) state by a time-dependent process.

The relationship of the above phenomenon to insulin degradation was examined by assessing the chemical nature of the radioactive material bound to the cells at different times of association and by measuring dissociation of both intact and degraded insulin. The results indicate that only intact insulin dissociates from the low affinity (fast dissociating) state of the receptor. In contrast, once the high affinity complexes are formed, both intact and degraded material can slowly dissociate. Insulin bound to the high affinity (slow dissociating) state of the receptor is a direct and efficient substrate for the insulin-degrading system. However, when insulin degradation was completely blocked by the sulfhydrylagent n-ethyl maleimide, the time-dependent slowing of dissociation of intact insulin was unaffected. Thus, development of the slow-dissociating state of the insulin receptor complex mediates cellular insulin degradation, but the process of insulin degradation is not necessary for the development of the slow-dissociating state of the insulin receptor complex. In conclusion: (a) A time-dependent slowing of the overall insulin dissociation rate was observed as the length of the association phase increased; however, no tendency toward irreversible binding of insulin to adipocytes was observed under any conditions, (b) This phenomenon is independent of a number of intracellular processes studied and is inherent in the plasma membrane, (c) The receptors to which insulin is bound early in the association phase do not degrade insulin, and, in fact, they protect the hormone from destruction, whereas a portion of the receptors to which insulin is bound late in the association phase mediate insulin degradation, (d) The data are consistent with the concept that insulin initially binds to a low affinity cell surface receptor and that some portions of these complexes are converted to a high affinity form by a time-dependent plasma membrane-associated process. The low affinity receptors have a rapid dissociation rate, are of high capacity, and do not degrade insulin. The high affinity receptors have a slow dissociation rate, are of low capacity, and mediate insulin degradation.

  • Accepted January 26, 1979.
  • Copyright © 1979 by the American Diabetes Association

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this Issue

May 1979, 28(5)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Interactions Between Insulin and Its Receptors After the Initial Binding Event: Functional Heterogeneity and Relationships to Insulin Degradation
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Interactions Between Insulin and Its Receptors After the Initial Binding Event: Functional Heterogeneity and Relationships to Insulin Degradation
Jerrold M Olefsky, Masashi Kobayashi, Helen Chang
Diabetes May 1979, 28 (5) 460-471; DOI: 10.2337/diab.28.5.460

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Interactions Between Insulin and Its Receptors After the Initial Binding Event: Functional Heterogeneity and Relationships to Insulin Degradation
Jerrold M Olefsky, Masashi Kobayashi, Helen Chang
Diabetes May 1979, 28 (5) 460-471; DOI: 10.2337/diab.28.5.460
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Metabolic and Vascular Factors in the Pathogenesis of Diabetic Neuropathy
  • The Role of Nutritional Modifications in the Prevention of Macrovascular Complications of Diabetes
  • Essential Fatty Acids in the Management of Impaired Nerve Function in Diabetes
Show more Articles

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.